ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Mayo Clinic Cancer Center Wins NCI Support Grant Renewal

June 19, 2009

Doctor-Patient Conversations At End of Life Associated With Lower Medical Expenses

March 27, 2009

NCAB Seeks Exemption From New Reimbursement Plan For Clinical Trials, Modification Of Hospice Regs

February 11, 1983

St. Jude Offers Three Fellowships

March 2, 1984

Nancy Davidson Elected ASCO President.

March 3, 2006

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013